Skip to main content
Top
Published in: Virology Journal 1/2023

Open Access 01-12-2023 | Uveitis | Research

Prevalence and characteristics of HTLV-associated uveitis in patients from Bahia, an endemic area for HTLV − 1 in Brazil

Authors: Daniele Piai Ozores, Regina Rathsam Pinheiro, Ney Boa-Sorte, Maurício Campos e Silva Dias, Raianne Silva Lima, Thessika Hialla Almeida Araújo, Bernardo Galvão-Castro, Maria Fernanda Rios Grassi

Published in: Virology Journal | Issue 1/2023

Login to get access

Abstract

Background

HTLV-1-associated uveitis (HAU) is an inflammatory reaction of the choroid, retina, optic nerve and vitreous that can lead to vision impairment. The worldwide prevalence of HAU varies widely.

Objective

To determine the prevalence of HAU in patients from Salvador, Bahia-Brazil, and describe uveitis type and associated symptoms.

Methods

Cross-sectional analytical study to determine the prevalence of uveitis in HTLV-1-infected patients recruited in Bahia, Brazil, a region considered endemic for HTLV-1. Patients were enrolled at a local reference center for HTLV (infected) and at an outpatient ophthalmology clinic (noninfected group). All patients were examined by the same ophthalmologist following a single protocol. Prevalence ratios (PR) were calculated.

Results

A total of 168 consecutively examined HTLV-1-infected patients and 410 noninfected patients (randomly selected) were included. Females predominated (82.1%) in the HTLV-1-infected group (versus 64.4% in the uninfected group) (p < 0.001). The mean age of infected and uninfected patients was 53.2 and 62.8 years, respectively (p < 0.001). The prevalence of uveitis in HTLV-1+ and HTLV-1 patients was 7.14% and 0.73%, respectively (PR = 9.76; 95CI%:2.79–34.15; p < 0.01). Bilateral intermediate uveitis, associated with symptoms including visual disturbances and floaters, was most commonly identified in the HTLV-1-infected patients, whereas unilateral anterior uveitis, in association with symptoms such as blurring and ocular pain, was more common in the uninfected group.

Conclusion

The prevalence of uveitis in patients with HTLV-1 was markedly higher than in uninfected subjects. HAU patients were mostly asymptomatic and exhibited bilateral presentation, with uveitis more frequently localized in the intermediate chamber.
Literature
6.
go back to reference Mochizuki M, Human T. -Lymphotropic virus type 1 and its ocular manifestations. Int Ophthalmol Clin. Published online 1995:107–20. Mochizuki M, Human T. -Lymphotropic virus type 1 and its ocular manifestations. Int Ophthalmol Clin. Published online 1995:107–20.
8.
go back to reference Osame M, Osame M. (1990). “Review of WHO kagoshima meeting and diagnostic guidelines for HAM/TSP,” Human retrovirology, ed. Blattner W. A. (New York, NY: Raven Press;), 191–7. Published online 1990. Osame M, Osame M. (1990). “Review of WHO kagoshima meeting and diagnostic guidelines for HAM/TSP,” Human retrovirology, ed. Blattner W. A. (New York, NY: Raven Press;), 191–7. Published online 1990.
10.
go back to reference Jabs DA, Nussenblatt RB, Rosenbaun JT. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am JnOphthalmol. 2005;140(3):509–16.CrossRef Jabs DA, Nussenblatt RB, Rosenbaun JT. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am JnOphthalmol. 2005;140(3):509–16.CrossRef
11.
go back to reference Kim ECFC. Immunomodulatory therapy for the treatment of ocular inflamatory disease: evidence-based medicine recommendations for use. Int Ophthalmol Clin. 2006;46(2):141–64.CrossRefPubMed Kim ECFC. Immunomodulatory therapy for the treatment of ocular inflamatory disease: evidence-based medicine recommendations for use. Int Ophthalmol Clin. 2006;46(2):141–64.CrossRefPubMed
12.
13.
go back to reference Kanski JJ. Oftalmologia Clínica Uma Abordagem Sistemática. 4 edição.; 2004. Kanski JJ. Oftalmologia Clínica Uma Abordagem Sistemática. 4 edição.; 2004.
15.
go back to reference Ikeda EKH, Ono A, Hikita N, Arima K, Mochizuki M, Yamaguchi K, Tajima K. Estimated prevalence rate of HTLV-1 uveitis in Chikugo. Nippon Ganka Gakkai zasshi. 1998;102:327–32.PubMed Ikeda EKH, Ono A, Hikita N, Arima K, Mochizuki M, Yamaguchi K, Tajima K. Estimated prevalence rate of HTLV-1 uveitis in Chikugo. Nippon Ganka Gakkai zasshi. 1998;102:327–32.PubMed
25.
go back to reference Fleiss JL. Statistical methods for Rates and Proportions. John Wiley & Sons; 1981. Fleiss JL. Statistical methods for Rates and Proportions. John Wiley & Sons; 1981.
26.
go back to reference Kanski JJ. Clinical Ophthalmology. A Systematic Approach. Vol 5. 5 edidition.; 2003. Kanski JJ. Clinical Ophthalmology. A Systematic Approach. Vol 5. 5 edidition.; 2003.
31.
go back to reference Mochizuki M, Sugita S, Kamoi K. Immunological homeostasis of the eye. Prog Retin Eye Res. 2012;(November):1–18. Mochizuki M, Sugita S, Kamoi K. Immunological homeostasis of the eye. Prog Retin Eye Res. 2012;(November):1–18.
35.
go back to reference Nakao K, Ohba N. Clinical features of HTLV-I associated uveitis. Br J Ophthalmol Published online 1993:274–9. Nakao K, Ohba N. Clinical features of HTLV-I associated uveitis. Br J Ophthalmol Published online 1993:274–9.
36.
go back to reference Takahashi T, Takase H, Urano T, Sugita S, Miyata N, Mochizuki M. Clinical features of human T-lymphotropic virus type 1 uveitis: a long-term follow-up. Ocul Immunol Inflamm. 2000;8(4):235–41.CrossRefPubMed Takahashi T, Takase H, Urano T, Sugita S, Miyata N, Mochizuki M. Clinical features of human T-lymphotropic virus type 1 uveitis: a long-term follow-up. Ocul Immunol Inflamm. 2000;8(4):235–41.CrossRefPubMed
Metadata
Title
Prevalence and characteristics of HTLV-associated uveitis in patients from Bahia, an endemic area for HTLV − 1 in Brazil
Authors
Daniele Piai Ozores
Regina Rathsam Pinheiro
Ney Boa-Sorte
Maurício Campos e Silva Dias
Raianne Silva Lima
Thessika Hialla Almeida Araújo
Bernardo Galvão-Castro
Maria Fernanda Rios Grassi
Publication date
01-12-2023
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2023
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/s12985-023-02135-7

Other articles of this Issue 1/2023

Virology Journal 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.